Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Increased myeloid-derived suppressor cells in gastric cancer correlate with cancer stage and plasma S100A8/A9 proinflammatory proteins.

Journal of immunology (Baltimore, Md. : 1950) - 15 Jan 2013

Wang Linda, Chang Esther W Y, Wong Siew Cheng, Ong Siew-Min, Chong Debra Q Y, Ling Khoon Lin

Abstract excerpt

Immune dysfunction may contribute to tumor progression in gastric cancer (GC) patients. One mechanism of immune dysfunction is the suppression of T cell activation and impairment of the efficacy of cancer immunotherapy by myeloid-derived suppressor cells (MDSCs). We assessed the phenotype and imm...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antigens, CD
Share to Arginase
Share to CD11b Antigen

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Immunophenotyping

Share to Lipopolysaccharide Receptors

Share to Myeloid Cells

Share to Nitric Oxide Synthase Type II

Share to Stomach Neoplasms

Source

Identifiers

PMID: 23248262
DOI: 10.4049/jimmunol.1202088

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026. Prepared record publication-23248262-2026-09-04.2. Manifest publication-graph-cohort-2026-09-04.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Increased myeloid-derived suppressor cells in gastric cancer correlate with cancer stage and plasma S100A8/A9 proinflammatory proteins.PMID 23248262Read ↗

Inhibition of dendritic cell differentiation and accumulation of myeloid-derived suppressor cells in cancer is regulated by S100A9 protein.Semantic proximity Read ↗

Insights into Myeloid-Derived Suppressor Cells in Inflammatory Diseases.Semantic proximity Read ↗

Myeloid-Derived Suppressor Cells in Solid TumorsSemantic proximity Read ↗

Myeloid-Derived Suppressor Cells in Colorectal CancerSemantic proximity Read ↗

Myeloid-Derived Suppressor Cells: Immune-Suppressive Cells That Impair Antitumor Immunity and Are Sculpted by Their Environment.Semantic proximity Read ↗

FasL+PD‐L2+ Identifies a Novel Immunosuppressive Neutrophil Population in Human Gastric Cancer That Promotes Disease ProgressionSemantic proximity Read ↗

The endogenous Toll–like receptor 4 agonist S100A8/S100A9 (calprotectin) as innate amplifier of infection, autoimmunity, and cancerSemantic proximity Read ↗

Increased frequency and clinical significance of myeloid-derived suppressor cells in human colorectal carcinoma.Semantic proximity Read ↗

CD8(+) T cells that produce interleukin-17 regulate myeloid-derived suppressor cells and are associated with survival time of patients with gastric cancer.Semantic proximity Read ↗

Epigenetic suppression of the immunoregulator MZB1 is associated with the malignant phenotype of gastric cancer.Semantic proximity Read ↗

Soluble HLA-G (sHLA-G) measurement might be useful as an early diagnostic biomarker and screening test for gastric cancerSemantic proximity Read ↗

Tumor-induced myeloid-derived suppressor cells promote tumor progression through oxidative metabolism in human colorectal cancer.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.